More than half of American workers — roughly 55 million — don't have access to a retirement savings plan on the job. Here's a potential fix. » Read More
By: Daniel Bukszpan
Based on the sheer quantity of rehashed material on tap, 2017 is quickly shaping up to be a big year for entertainment deja vu. » Read More
CNBC's Jane Wells has a news flash for all the millennials: You're not really sharing anything. You're paying for services.
Investors should stop the doom and gloom, says Debra Silversmith. Election year markets generally go higher.
Einhorn took a bruising in the markets last year, but at least one of his apparent strategies is now paying off handsomely.
The slowdown in the U.S. economy at the start of 2016 could prompt the Fed to slow its move to raise interest rates.
A study by academic researchers shows that almost half the time, stocks rise in the days following a CEO's sudden passing.
Imagine getting a phone call where a relative stranger informed you that you were now a billionaire.
U.S. economic growth looks poised to pick up after a weak first quarter, keeping with the trend of recent years, analysts tell CNBC.
This is about to become the second-longest bull market ever.
Atari founder Nolan Bushnell is trying his hand at mobile games for the first time, partnering with Spil Games to develop new titles.
Apple's latest quarterly results are less than encouraging, but the numbers may not be as bad as they look.
David Klein, CEO of online lender CommonBond, explains how his start-up is on track to surpass $1 billion in total loans funded.
Most companies sit on cybersecurity breaches for weeks — while they take hackers only minutes to perpetrate.
The official trailer for Oliver Stone's Edward Snowden biopic "Snowden" arrived online on Wednesday.
Twitter CEO Jack Dorsey sat down for an interview to talk about what Wall Street has wrong about the company, and what his vision is.
If you've ever taken a deep breath in Beijing, you'll understand why Tesla is so excited about "bioweapon defense mode."
The 300 million pain prescriptions written last year equal a $24B market, but it's not a market evenly divided around the globe.